MarketInOut Stock Screener Log In | Sign Up
 

Veradermics Inc

NYSE • Healthcare • Biotechnology • Quote as of 10/23/2026
Veradermics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNYSE
Market Capitalization5,310.67 mln
Float30.25 mln
Earnings Date11/30/2026

1-Year Forecast

164.83
Attractive

Relative Strength

88 / 100
Strongly outperforming

Debt / Equity

0.00
Debt-free

ROE

-16.11
Negative

ROA

-15.79
Deeply negative

Business Description

Veradermics is a New Haven, Connecticut-based medical company founded in 2019 that creates new treatments for skin and hair conditions in both adults and children. Its pipeline includes an oral non-hormonal pill for chronic hair loss, a dissolving patch that delivers immunotherapy for common warts, and targeted therapies for alopecia areata and molluscum contagiosum. The company works closely with dermatologists, clinicians, and medical researchers to bring these solutions to patients.

Key Fundamentals

EPS-4.24
ROE-16.11
ROIC-1,026
ROA-15.79
Interest Cover-193
EBITDA, mln-72.05
EV / EBITDA-59.02
EV / EBIT-59.02

Quote Details

Last 138.78
Change 0.29 (0.21%)
Open 139.44
Volume 423,072
Turnover 58,713,932
Average Volume 871,882

Financial Ratios

Leverage Ratio1.01
Current Ratio70.53
Price / Book6.23
Price / Tangible Book6.23
Debt / Equity0.00

Financial Strength

1-Year Target Price164.83
Short Ratio5.78
Short % of Float15.60

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 27.53% 100 / 100   
1 Month 19.93% 98 / 100   
2 Months 30.88% 97 / 100   
6 Months 105% 100 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog